PMID- 35293029 OWN - NLM STAT- MEDLINE DCOM- 20220412 LR - 20220414 IS - 1098-2825 (Electronic) IS - 0887-8013 (Print) IS - 0887-8013 (Linking) VI - 36 IP - 4 DP - 2022 Apr TI - Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly. PG - e24350 LID - 10.1002/jcla.24350 [doi] LID - e24350 AB - OBJECTIVE: To investigate the relationship between serum lutein and type 2 diabetes mellitus (T2DM) and diabetic kidney disease (DKD) in elderly individuals. METHODS: A total of 60 T2DM patients over 60 years were subgrouped into a DKD group and a non-DKD group according to their urinary microalbumin-to-creatinine ratio (UACR), while 30 age-matched non-T2DM patients were recruited in the control group. Baseline characteristics, laboratory examination results, and serum lutein levels were compared, and their correlations were analyzed. Receiver operating characteristic (ROC) curves were plotted to identify the diagnostic potential of lutein in T2DM and DKD. RESULTS: The lutein level in the T2DM group was significantly lower than that in the control group and was also significantly lower in the DKD group than in the non-DKD group (p < 0.001). Lutein levels were negatively correlated with body mass index, glycosylated hemoglobin, fasting blood glucose, triglyceride, and UACR and positively correlated with high-density lipoprotein cholesterol (p < 0.05). T2DM patients were divided into four groups according to the quartile of their lutein level. The proportion of T2DM and DKD gradually decreased with increasing lutein levels (p < 0.001). The area under the ROC curve of serum lutein in diagnosing T2DM and DKD was 0.880 and 0.779, respectively, with corresponding cut-off values of 0.433 mumol/L and 0.197 mumol/L (p < 0.001). CONCLUSION: The serum level of lutein is negatively correlated with the incidence of T2DM and DKD in the elderly and can serve as a diagnostic marker for T2DM and DKD. CI - (c) 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. FAU - Pan, Fenghui AU - Pan F AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. FAU - Cui, Wenxia AU - Cui W AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. FAU - Gao, Lei AU - Gao L AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. FAU - Shi, Xiaoting AU - Shi X AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. FAU - Yang, Haiyan AU - Yang H AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. FAU - Hu, Yun AU - Hu Y AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. FAU - Li, Man AU - Li M AUID- ORCID: 0000-0001-5328-7322 AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. LA - eng GR - 82003823/The National Natural Science Foundation of China/ GR - BJ17003/Foundation of Jiangsu Province Health Bureau/ GR - BJ18008/Foundation of Jiangsu Province Health Bureau/ PT - Journal Article DEP - 20220315 PL - United States TA - J Clin Lab Anal JT - Journal of clinical laboratory analysis JID - 8801384 RN - 0 (Biomarkers) RN - X72A60C9MT (Lutein) SB - IM MH - Aged MH - Biomarkers MH - *Diabetes Mellitus, Type 2 MH - *Diabetic Nephropathies MH - Humans MH - Lutein MH - ROC Curve PMC - PMC8993643 OTO - NOTNLM OT - biomarker OT - diabetic kidney disease OT - lutein OT - type 2 diabetes mellitus COIS- The authors declare that there are no conflicts of interest. EDAT- 2022/03/17 06:00 MHDA- 2022/04/13 06:00 PMCR- 2022/03/15 CRDT- 2022/03/16 05:59 PHST- 2022/02/15 00:00 [revised] PHST- 2021/12/26 00:00 [received] PHST- 2022/03/05 00:00 [accepted] PHST- 2022/03/17 06:00 [pubmed] PHST- 2022/04/13 06:00 [medline] PHST- 2022/03/16 05:59 [entrez] PHST- 2022/03/15 00:00 [pmc-release] AID - JCLA24350 [pii] AID - 10.1002/jcla.24350 [doi] PST - ppublish SO - J Clin Lab Anal. 2022 Apr;36(4):e24350. doi: 10.1002/jcla.24350. Epub 2022 Mar 15.